Glycated hemoglobin measurement and prediction of cardiovascular disease

E. Di Angelantonio, P. Gao, H. Khan, E.J.M. Feskens

Research output: Contribution to journalArticleAcademicpeer-review

134 Citations (Scopus)

Abstract

(For a complete list of authors see The Emerging Risk Factors Collaboration in the Article Information) Importance The value of measuring levels of glycated hemoglobin (HbA1c) for the prediction of first cardiovascular events is uncertain. Objective To determine whether adding information on HbA1c values to conventional cardiovascular risk factors is associated with improvement in prediction of cardiovascular disease (CVD) risk. Design, Setting, and Participants Analysis of individual-participant data available from 73 prospective studies involving 294¿998 participants without a known history of diabetes mellitus or CVD at the baseline assessment. Main Outcomes and Measures Measures of risk discrimination for CVD outcomes (eg, C-index) and reclassification (eg, net reclassification improvement) of participants across predicted 10-year risk categories of low (
Original languageEnglish
Pages (from-to)1225-1233
JournalJAMA: The Journal of the American Medical Association
Volume311
Issue number12
DOIs
Publication statusPublished - 2014

Keywords

  • statistical-methods
  • diabetes-mellitus
  • risk score
  • task-force
  • glucose
  • guidelines
  • metaanalysis
  • mortality
  • adults

Fingerprint Dive into the research topics of 'Glycated hemoglobin measurement and prediction of cardiovascular disease'. Together they form a unique fingerprint.

Cite this